Dianshan Ke

621 total citations
24 papers, 449 citations indexed

About

Dianshan Ke is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dianshan Ke has authored 24 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Dianshan Ke's work include Bone Metabolism and Diseases (11 papers), Bone health and treatments (5 papers) and Bone and Joint Diseases (5 papers). Dianshan Ke is often cited by papers focused on Bone Metabolism and Diseases (11 papers), Bone health and treatments (5 papers) and Bone and Joint Diseases (5 papers). Dianshan Ke collaborates with scholars based in China and United States. Dianshan Ke's co-authors include Weifeng Xu, Xiaomin Fu, Beibei Chen, Xiaobing Chen, Jianming Hou, Ying Xue, Xinwen Wang, Xinwei Chen, Xinwu Wang and Junyong Han and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Dianshan Ke

22 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dianshan Ke China 14 277 130 102 94 91 24 449
Qi Xiong China 12 259 0.9× 254 2.0× 127 1.2× 65 0.7× 69 0.8× 35 571
Liang Deng China 15 327 1.2× 74 0.6× 74 0.7× 62 0.7× 85 0.9× 42 521
Hiroyuki Hounoki Japan 11 188 0.7× 92 0.7× 43 0.4× 72 0.8× 55 0.6× 27 400
Hongsheng Yang China 14 226 0.8× 85 0.7× 113 1.1× 71 0.8× 61 0.7× 32 503
Jukka P. Rissanen Finland 10 225 0.8× 245 1.9× 41 0.4× 52 0.6× 21 0.2× 24 580
Bo Pang China 13 142 0.5× 77 0.6× 104 1.0× 175 1.9× 48 0.5× 26 462
Jian Xiao China 16 177 0.6× 254 2.0× 104 1.0× 91 1.0× 105 1.2× 51 642
Justyna Kiszałkiewicz Poland 15 203 0.7× 72 0.6× 114 1.1× 93 1.0× 22 0.2× 35 451
Linlin Xu China 9 137 0.5× 74 0.6× 34 0.3× 75 0.8× 26 0.3× 35 357
Zheng Liang China 10 134 0.5× 81 0.6× 58 0.6× 76 0.8× 20 0.2× 34 340

Countries citing papers authored by Dianshan Ke

Since Specialization
Citations

This map shows the geographic impact of Dianshan Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianshan Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianshan Ke more than expected).

Fields of papers citing papers by Dianshan Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianshan Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianshan Ke. The network helps show where Dianshan Ke may publish in the future.

Co-authorship network of co-authors of Dianshan Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Dianshan Ke. A scholar is included among the top collaborators of Dianshan Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianshan Ke. Dianshan Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Fu, Xiaomin, Yuhan Wang, Nan Li, et al.. (2023). Implementation of five machine learning methods to predict the 52-week blood glucose level in patients with type 2 diabetes. Frontiers in Endocrinology. 13. 1061507–1061507. 6 indexed citations
4.
Xue, Ying, et al.. (2023). GPER1 contributes to T3-induced osteogenesis by mediating glycolysis in osteoblast precursors. Experimental Biology and Medicine. 248(20). 1732–1744.
6.
Wu, Haojie, et al.. (2023). IL-17A inhibits the degradation of RANKL in osteoblasts by inhibiting BCL2-Beclin1-autophagy signaling. In Vitro Cellular & Developmental Biology - Animal. 59(4). 300–311. 4 indexed citations
7.
Fu, Xiaomin, Hongzhou Liu, Jing Liu, et al.. (2022). Association Between Triglyceride–Glucose Index and the Risk of Type 2 Diabetes Mellitus in an Older Chinese Population Aged Over 75 Years. Frontiers in Public Health. 9. 796663–796663. 14 indexed citations
8.
Ke, Dianshan, et al.. (2022). Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis. Molecular Medicine. 28(1). 22–22. 19 indexed citations
9.
Luo, Jun, et al.. (2022). Research trends of mesenchymal stem cells application in orthopedics: A bibliometric analysis of the past 2 decades. Frontiers in Public Health. 10. 1021818–1021818. 7 indexed citations
10.
Ke, Dianshan, et al.. (2021). Lactoferrin promotes the autophagy activity during osteoblast formation via BCL2-Beclin1 signaling. Molecular Biology Reports. 49(1). 259–266. 6 indexed citations
11.
Wang, Xinwen, Liangming Wang, Weifeng Xu, et al.. (2021). Classification of Osteosarcoma Based on Immunogenomic Profiling. Frontiers in Cell and Developmental Biology. 9. 696878–696878. 14 indexed citations
12.
Wang, Xinwen, Feng Liu, Dianshan Ke, et al.. (2021). An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology. 12. 781466–781466. 85 indexed citations
13.
Xu, Weifeng, Beibei Chen, Dianshan Ke, & Xiaobing Chen. (2020). MicroRNA-138-5p targets the NFIB-Snail1 axis to inhibit colorectal cancer cell migration and chemoresistance. Cancer Cell International. 20(1). 475–475. 18 indexed citations
14.
Ke, Dianshan, et al.. (2020). Puerarin inhibits the migration of osteoclast precursors and osteoclastogenesis by inhibiting MCP-1 production. Bioscience Biotechnology and Biochemistry. 84(7). 1455–1459. 6 indexed citations
15.
Cheng, Liang, et al.. (2020). Oestrogen‐activated autophagy has a negative effect on the anti‐osteoclastogenic function of oestrogen. Cell Proliferation. 53(4). e12789–e12789. 24 indexed citations
16.
Ke, Dianshan, Yu Wang, Zheng Wang, et al.. (2019). Curcumin-activated autophagy plays a negative role in its anti-osteoclastogenic effect. Molecular and Cellular Endocrinology. 500. 110637–110637. 18 indexed citations
17.
Ke, Dianshan, et al.. (2019). Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis. Biochimie. 167. 217–227. 18 indexed citations
18.
Ke, Dianshan, Yu Wang, Xiaomin Fu, et al.. (2019). JNK1 regulates RANKL‐induced osteoclastogenesis via activation of a novel Bcl‐2‐Beclin1‐autophagy pathway. The FASEB Journal. 33(10). 11082–11095. 38 indexed citations
19.
Fu, Xiaomin, et al.. (2018). IL-17A modulates osteoclast precursors' apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis. Biochemical and Biophysical Research Communications. 508(4). 1088–1092. 32 indexed citations
20.
Ke, Dianshan, Xiaomin Fu, Ying Xue, et al.. (2018). IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro. Biochemical and Biophysical Research Communications. 497(3). 890–896. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026